Drug treatment of BPH was initially viewed with suspicion by ... from baseline in the American Urological Association symptom score, acute urinary retention, urinary tract infection, urosepsis ...

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on Wednesday, April 2nd, IPO Scoop reports. The company plans to issue 2,700,000 shares at $7.50-$8.50 per share. The ...

New procedures are less invasive than many older choices, with good results and comfortable recovery. Although there is no cure for benign prostatic hyperplasia (BPH), also known as enlarged prostate, ...

Predictors of Achieving a Minimal Clinically Important Difference in Lower Urinary Tract Symptoms 3 Months after Rezum Therapy - Beyond the Abstract ...

“While there are other treatment options available for treating BPH, there remains a significant need for much less invasive treatment approaches that can preserve and protect the integrity of the ...

As men get older, their risk for developing an enlarged prostate gland increases. This condition, known as Benign Prostatic Hyperplasia, or BPH, affects about half of men between the ages of 51 and 60 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Investments in biotechnology and oil and gas exploration entities.

One factor they consider is your credit score, a three-digit number calculated by analyzing your financial actions — such as debt and payment history, the age of your accounts and your credit mix.

Check your free credit score and credit report as often as you want, and get alerts about changes so you can manage your credit effectively. Credit education Stay on top of your score with ...